Farzanna S Haffizulla MD, FACP, FAMWA
Chair, Department of Internal Medicine, Nova Southeastern University’s Dr. Kiran C. Patel College of Osteopathic Medicine; National President of the American Medical Women’s Association (AMWA) 2014–2015; Private Practice, Internal Medicine, Davie, FloridaDr. Farzanna Haffizulla practices general internal medicine in Davie, Florida, within her own internal medicine concierge practice. Her practice allows her to offer office visits, house calls, and telemedicine to her patients with an innovative, creative approach which allows her to fuse traditional clinical practice with technology.
Dr. Haffizulla is a Founding Team Member and Former Assistant Dean, Community and Global Health at Nova Southeastern University’s Dr. Kiran C. Patel College of Allopathic Medicine. She now serves as Chair of the Department of Internal Medicine at NSU's DR. Kiran C. Patel College of Osetopathic Medicine.
Dr. Haffizulla is the 2014–2015 national President of the American Medical Women’s Association (AMWA), and she served as the South Florida AMWA branch President and was one of its founding officers. She is involved on many levels with AMWA, including being the Chair and Founder for AMWA’s Preventive Medicine Task Force, and founder of AMWA’s Fellowship program.
In addition to being a nationally recognized speaker and expert on work–life balance, Dr. Haffizulla speaks nationally on improving cohesion among healthcare organizations and physicians. She is the on-camera show host, anchor, and medical correspondent for the nationwide health program, Mission Critical Health.
She currently teaches honors organic chemistry to the premed seniors at American Heritage School, and she is an affiliate Clinical Assistant Professor of Biomedical Science at the Charles E. Schmidt College of Medicine at Florida Atlantic University and a voluntary Assistant Professor of Medicine at the University of Miami.
Dr. Haffizulla completed medical school at the University of Miami Miller School of Medicine. Her residency training was at the Cleveland Clinic Florida and at the Cleveland Clinic Foundation in Ohio; she is board-certified in internal medicine. Her clinical interests include diabetes, hypertension, and hyperlipidemia.
Recent Contributions to PracticeUpdate:
- Rucaparib for Advanced Urothelial Carcinoma
- Pembrolizumab for Patients With High-Risk, Non-Muscle Invasive Bladder Cancer
- Androgen Deprivation Therapy Plus Enzalutamide for Hormone-Sensitive Prostate Cancer
- Pembrolizumab for Non-Clear Cell RCC
- A Novel Tubulin Inhibitor, VERU-111, for mCRPC
- PT2977 for VHL-Associated RCC
- Implementation of a Community-Based Breast Cancer Management Program in Peru
- Ipilimumab Plus Nivolumab for mCRPC
- Key Data From ASCO GU 2019 on mRCC
- Key Data From ASCO GU 2019 on mRCC: Pembrolizumab and Axitinib as First-Line Therapy